Hydropothecary Announces Stock Option Grants to Officers and Employees

Imprimer
| Source : The Hydropothecary Corporation
communiqué multilingue

GATINEAU, Quebec, April 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE:THCX) announces that it has made a grant of stock options under its stock option plan to certain of its officers to acquire a total of 845,000 common shares of the Company. In addition, the Company has granted options to acquire an aggregate of 61,500 common shares of the Company to certain non-executive employees. All of the options are exercisable at a price of $4.27 per share. One-third of the options will vest on the one year anniversary of the date of grant and the balance will vest quarterly over two years thereafter. The options have a term of 10 years and are subject in all respects to the terms of THCX's stock option plan and the requirements of the TSX Venture Exchange.

About Hydropothecary Corporation

The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations. Hydropothecary creates award-winning innovative, easy to use and easy to understand products. Hydropothecary is rapidly increasing its production capacity in the lead-up to recreational adult-use cannabis. Expansion plans will result in a total of 1.3 million sq. ft. of production space, producing 108,000 kg of dried cannabis per year, making Hydropothecary one of the largest producers in the country. The first licensed producer in Quebec, Hydropothecary is headquartered in the province.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Media Contact Information
Shawn Lyons
Manager, Media Relations and Strategic Communications
819-576-3637
shawn.lyons@thehydropothecary.com

Investor Relations Contact Information
Jennifer Smith
Manager of Financial Reporting and Investor Relations
1-866-438-THCX (8429)
invest@THCX.com
www.THCX.com

Director
Adam Miron
819-639-5498